Clinical impact of a surgical energy device in advanced ovarian cancer surgery including bowel resection

Giuseppe Vizzielli, Carmine Conte, Massimo Romano, Anna Fagotti, Barbara Costantini, Claudio Lodoli, Salvatore Gueli Alletti, Khaled Gaballah, Fabio Pacelli, Alfredo Ercoli, Giovanni Scambia, Valerio Gallotta

Research output: Contribution to journalArticlepeer-review


Aim: To evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. Patients and Methods: This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nervesparing surgery was analyzed before and 6 months after surgery. Results: Forty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted. Conclusion: Caiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.

Original languageEnglish
Pages (from-to)359-364
Number of pages6
JournalIn Vivo
Issue number2
Publication statusPublished - Mar 1 2018


  • Caiman®
  • Energy device
  • Ovarian cancer
  • Surgery

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology


Dive into the research topics of 'Clinical impact of a surgical energy device in advanced ovarian cancer surgery including bowel resection'. Together they form a unique fingerprint.

Cite this